West Nile Virus detected in New Orleans mosquitoes, city expands control measures
No human cases have been reported so far, but officials say the presence of the virus in local mosquito traps is a clear warning sign.
'We are collecting mosquitoes every Monday and Tuesday,' said Claudia Riegel, Director of the City's Mosquito, Termite, and Rodent Control Board. 'We're monitoring which species are present and whether they're carrying any viruses that could impact our residents or even their pets.'
City of New Orleans, Orleans Parish School Board back in court involving $90M negotiation
In response, mosquito control crews are actively treating neighborhoods by both truck and helicopter, using a combination of larvicide and adulticide to disrupt breeding and reduce adult mosquito populations. The city currently maintains 89 trap locations, where mosquito samples are tested weekly for West Nile, Eastern Equine Encephalitis and St. Louis Encephalitis.
Officials stress that even small amounts of standing water, inside trash bins, tires, clogged gutters or yard debris can serve as mosquito breeding grounds.
'We want to make sure that when people put debris out, they bag it tightly so no water collects inside,' said Matt Torri with the city's Department of Sanitation.
Health officials also caution that while most people infected with West Nile won't experience symptoms, a small percentage can become seriously ill.
'Roughly four out of five people will have no symptoms at all,' said Meredith McInturff with the New Orleans Health Department. 'But for the unlucky one in five, symptoms can include fever, fatigue and respiratory issues that last for several days or even weeks.'
The city recommends using EPA and CDC approved mosquito repellents, emptying containers that hold water and keeping yards clear of debris. Residents can report mosquito problems or request tire pickup and additional trash bins by calling 311.Orleans mother suspects foul play in daughter's Riverwalk death
West Nile Virus detected in New Orleans mosquitoes, city expands control measures
Two killed in Jefferson Parish car crash
Hardline House conservatives swing for fences in asks to Senate GOP on megabill
Start times for Men's College World Series revealed
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Politico
18 hours ago
- Politico
Wiles intervened to save RFK Jr.'s top vaccine aide
Trump's reversal demonstrated the limits of Loomer's influence and marked a fragile win for Kennedy in pursuing his plans to overhaul U.S. regulation of vaccines and drugs — and confirmation that the White House still sees Kennedy as a useful political ally as the midterm elections approach. Trump had forced Prasad out of his FDA job less than two weeks earlier after the Cambridge, Massachusetts, pharmaceutical manufacturer Sarepta Therapeutics, joined by GOP allies and Loomer, sought his ouster. Prasad in July had pushed the FDA to ask Sarepta to stop selling its Duchenne muscular dystrophy drug Elevidys due to safety concerns, according to one of the senior administration officials. Sarepta spokesperson Tracy Sorrentino wrote in an email that the company will 'continue working with the FDA, its leadership and review teams, as we have always done.' In arguing Prasad was disloyal to Trump, Loomer had pointed to social media posts he made during the pandemic, in which Prasad said that he was once a Bernie Sanders supporter. Prasad's rehiring isn't the end of the war between Kennedy and his allies, and Loomer and corporations – from pharma to food manufacturers – that see Kennedy as a threat. Loomer, for instance, has only amped up her critique, most recently telling POLITICO that she planned to go after more Kennedy aides. Loomer remains close to Trump, and he has occasionally, though not always, followed her advice on personnel decisions. Loomer did not respond immediately to a request for comment. The FDA referred questions to the White House. 'Secretary Kennedy and the entire HHS team are doing a terrific job as they deliver on President Trump's mandate to Make America Healthy Again,' White House spokesperson Kush Desai said. 'Scores of prominent restaurant chains and food brands dropping artificial ingredients from our food supply and historic reforms at the FDA to fast track lifesaving drugs and treatments prove that the entire HHS team is delivering for the American people.' According to the officials, Makary and Kennedy persuaded the White House to review statements by Prasad that Loomer said showed disloyalty, arguing they were taken out of context. 'I think it really is something good about the president that he's willing to change his mind when persuaded,' one of the senior administration officials said. But the victory could prove pyrrhic if Prasad's ability to set policy is diminished. Before his firing, Makary had named him not only the head of the FDA's Center for Biologics Evaluation and Research, which oversees regulation of vaccines and gene therapies like Elevidys, but also the agency's chief medical and scientific officer. Makary, like Prasad, was a leading critic of the Biden administration's response to the Covid pandemic. Prasad, a University of Chicago-trained hematologist and oncologist, was previously a professor of epidemiology and biostatistics at the University of California, San Francisco. Sen. Ron Johnson (R-Wis.), the author of a 2018 law Trump signed that permits patients greater access to experimental therapies, told POLITICO he texted Trump days ahead of Prasad's ouster to raise concerns of the Duchenne muscular dystrophy patient community about the FDA's efforts to restrict Elevidys. The company initially refused to comply with the agency's July 18 request that it halt shipment. It agreed on July 21 to stop shipping the medicine by the end of business the next day to maintain a 'productive and positive working relationship with FDA.' The agency then allowed the company to resume distribution to ambulatory patients on July 28, a day before Prasad's ouster. Those patients are a subset of people with the condition, which weakens muscles and leads to the loss of the ability to walk, typically by age 12. Most die before they reach 30. Johnson's Right to Try Act, which Trump repeatedly touted on the campaign trail as a signature achievement of his first term, aims to allow patients with life-threatening diseases to try experimental medicines without FDA involvement. The agency has a separate longstanding program known as compassionate use that allows such patients to access experimental treatments when other options do not exist. 'I have never met or spoken to Dr. Prasad,' Johnson said when asked about Prasad's return. 'I hope all the new appointees within HHS and its subsidiary agencies restore integrity to scientific research, fully respect both the letter and spirit of the Right to Try Act, and carefully listen to and empathize with the patients who are impacted by their decisions.' Former FDA officials said they expect the power struggle between Republicans who support pharma and Kennedy to continue. Loomer, meanwhile, says she now wants Trump to dismiss Stefanie Spear, Kennedy's principal deputy chief of staff and senior counselor, and Casey Means, Trump's nominee to be surgeon general. Casey Means is a close Kennedy ally and sister of Kennedy adviser Calley Means. 'I think she wants to split the MAHA and MAGA coalition,' one of the senior officials said of Loomer. 'She wants to split them in two.'
Axios
19 hours ago
- Axios
First West Nile virus case confirmed in Salt Lake County
The Salt Lake County Health Department is warning residents to protect themselves against mosquito bites after confirming the first human case of the West Nile virus in 2025. The big picture: The adult was likely infected "with a more severe form of the disease" in late July, close to the Jordan River in the southern part of the county, and hospitalized, the health department's investigation revealed Thursday. They are now recovering at home. Catch up quick: Mosquito abatement districts in Salt Lake City, South Salt Lake and Magna have found the insects infected with the virus so far this season. 14 people in Utah became infected with the disease last year and one person died after contracting it in 2023. Threat level: The virus can cause mild to severe health complications, including a fever, headache, body aches, vomiting, diarrhea or a rash, according to the Centers for Disease Control and Prevention. Symptoms typically appear two to 14 days after a bite. Less than 1% of infections result in severe health outcomes or death, per the CDC. People ages 50 and older with weakened immune systems carry the highest risk of illness, according to the health department. County health officials released tips to avoid mosquito exposure:
Forbes
19 hours ago
- Forbes
Republican Congressman Introduces Bill To Reschedule Cannabis
GOP Rep. Greg Steube of Florida this week introduced a bill that would reclassify cannabis under federal drugs laws. Steube filed the measure, dubbed the Marijuana 1-to-3 Act, in the House of Representatives on Tuesday, according to a report from online cannabis news source Marijuana Moment. If passed, the bill would remove marijuana from Schedule I of the federal Controlled Substances Act (CSA) and place it in Schedule III, a less restrictive classification that would likely ease research and improve the business climate for regulated cannabis companies. Bill Codifies Biden Administration Cannabis Rescheduling Proposal Steube's bill would have the same effect as an October 2022 proposal developed by the Department of Health and Human Services under the Biden administration. A decision on that proposal, which is still pending with the Drug Enforcement Administration after progress stalled in January, is expected within 'the next few weeks,' according to a statement from President Donald Trump earlier this week. Steube has introduced the Marijuana 1-to-3 Act (H.R. 4963) in the House each of the past four legislative sessions. The two-page measure mandates that 'the Attorney General of the United States shall, by order not later than 60 days after the date of enactment of this section, transfer marijuana…from schedule I of such Act to schedule III' of the CSA. The Florida Republican announced on Monday via a post on social media that he would be introducing the cannabis rescheduling bill again for the current session. 'It makes zero sense that federal law treats marijuana the same as heroin and LSD,' Steube said in a post on the platform X. 'It is even more ridiculous that cocaine is technically classified as less restrictive than marijuana.' 'This week, I'm reintroducing my Marijuana 1-to-3 Act to move marijuana from Schedule I to Schedule III under the Controlled Substances Act. This is a common-sense change that will finally allow real scientific research into its medicinal value and ensure our drug laws reflect reality,' he added. 'I urge my colleagues and the Trump administration to get it done.' Cannabis CEO Sees 'Rare Opportunity' For Trump Peter Barsoom, founder and CEO of cannabis edibles brand 1906, says that Steube's bill would benefit consumers as well as regulated cannabis companies. 'Codifying cannabis reform through legislation would give the industry the stability it needs to invest, innovate, and expand access, while ensuring patients and consumers nationwide can benefit from safe, regulated products,' Barsoom writes in an emailed statement. 'Millions of Americans already use it to sleep better, manage pain, reduce anxiety, and improve quality of life – often as a safer alternative to alcohol or more dangerous drugs,' he added. 'With this bill, the Trump administration has a rare opportunity to end decades of wasted tax dollars, needless arrests, and blocked medical breakthroughs.' Trump Administration On Rescheduling Coming Soon Steube filed his bill only one day after Trump made his first public comments about cannabis policy reform since taking office in January. On Monday, the president said during a press conference that his administration will soon decide on the rescheduling proposal. 'Some people like it. Some people hate it—people hate the whole concept of marijuana, because it does bad for the children [and] it does bad for people that are older than children,' Trump said at the press conference. 'But we're looking at reclassification, and we'll make a determination over the next few weeks—and that determination, hopefully, will be the right one.'
